AudiologyOnline Phone: 800-753-2160


Oticon Medical Ponto 5 Family - April 2022

Research on Mild and/or Unilateral Hearing Loss (R21)

Share:
NIH/CDC research grant opportunity

National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC)
grants.nih.gov/grants/guide/pa-files/PA-07-037.html

Application Submission/Receipt Date(s): Standard dates apply, see grants1.nih.gov/grants/funding/submissionschedule.htm

Budget and Project Period: The total project period for an application submitted in response to this funding opportunity may not exceed two years. Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year.

This Funding Opportunity Announcement (FOA) solicits R21 applications to further our understanding of mild and unilateral hearing loss in infants and young children. This includes research on prevention, better diagnostic methods, and treatments for these forms of hearing loss that are often overlooked or minimized. Children with milder forms of hearing loss (e.g.,
Rexton Reach - April 2024

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.